Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    19332717 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas
Condition: Chondrosarcoma
Interventions: Drug: Everolimus 2.5 mg/day;   Drug: Everolimus 10 mg/day
2 Unknown  1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC
Condition: Clear Cell Renal Cell Carcinoma
Intervention: Drug: Dovitinib

Study has passed its completion date and status has not been verified in more than two years.